Insulin Receptor – Agonists and Antagonists Agents Curator: Larry H Bernstein, MD, FCAP   SerpinB1 Promotes Pancreatic β Cell Proliferation: Implications for Treatment of Diabetes http://pharmaceuticalintelligence.com/2015/12/20/serpinb1-promotes-pancreatic-%CE%B2-cell-proliferation-implications-for-treatment-of-diabetes/ Peroxisome proliferator-activated receptor (PPAR-gamma) Receptors Activation: PPARγ transrepression for Angiogenesis in Cardiovascular Disease and PPARγ transactivation for Treatment of Diabetes http://pharmaceuticalintelligence.com/2012/11/13/peroxisome-proliferator-activated-receptor-ppar-gamma-receptors-activation-ppar%CE%B3-transrepression-for-angiogenesis-in-cardiovascular-disease-and-ppar%CE%B3-transactivation-for-treatment-of-dia/   Overview of New Strategy for Treatment of T2DM: SGLT2 … Continue reading Insulin Receptor – Agonists and Antagonists Agents